Docosahexaenoic acid inhibits the proliferation of Kras/TP53 double mutant pancreatic ductal adenocarcinoma cells through modulation of glutathione level and suppression of nucleotide synthesis-Reference-Cited by-同舟云学术

Docosahexaenoic acid inhibits the proliferation of Kras/TP53 double mutant pancreatic ductal adenocarcinoma cells through modulation of glutathione level and suppression of nucleotide synthesis

Published:2020-11-02 Issue:11 Volume:15 Page:e0241186
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hung Wei-Chia,Lee Der-Yen,Chiang En-Pei Isabel,Syu Jia-Ning,Chao Che-Yi,Yang Mei-Due,Tsai Shu-Yao,Tang Feng-Yao^ORCID

Funder

Ministry of Science and Technology, Taiwan

China Medical University

Ministry of Education

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. Cancer statistics, 2018;RL Siegel;CA Cancer J Clin,2018

2. Vagaries of clinical presentation of pancreatic and biliary tract cancer;I Modolell;Annals of oncology: official journal of the European Society for Medical Oncology,1999

3. Pancreatic adenocarcinoma;DP Ryan;N Engl J Med,2014

4. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets;AK Witkiewicz;Nat Commun,2015

5. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism;H Ying;Cell,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. d-α-tocopheryl polyethylene glycol 1000 succinate surface scaffold polysarcosine based polymeric nanoparticles of enzalutamide for the treatment of colorectal cancer: In vitro, in vivo characterizations;Heliyon;2024-02

2. Genome, Metabolism, or Immunity: Which Is the Primary Decider of Pancreatic Cancer Fate through Non-Apoptotic Cell Death?;Biomedicines;2023-10-14

3. Docosahexaenoic Acid Inhibits Cell Proliferation through a Suppression of c-Myc Protein in Pancreatic Ductal Adenocarcinoma Cells;Antioxidants;2021-10-28

4. Sulfasalazine Sensitizes Polyhematoporphyrin-Mediated Photodynamic Therapy in Cholangiocarcinoma by Targeting xCT;Frontiers in Pharmacology;2021-08-13